Clinical Profile and Outcome of Adult Classical Hodgkin’s Lymphoma: Real World Single Centre Experience
- 9 February 2024
- journal article
- research article
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 40 (3) , 392-399
Abstract
Hodgkin’s lymphoma treatment outcomes have been the true success story of modern medicine. Various data from western as well as Indian studies are available for classical Hodgkin’s lymphoma (cHL). Here we report treatment outcomes from a tertiary cancer care centre in Karnataka over a 5 year period. This was a retrospective review of cHL cases aged 15 years and above diagnosed between January 2015 and December 2019 at Kidwai Memorial Institute of Oncology, Bengaluru, Karnataka, India. The case files of the patients were retrieved and relevant data was collected. Two hundred patients of cHL were included in this study. Median age was 28 years with male to female ratio of 1.56:1. B symptoms were present in 58% cases. Mixed cellularity (46.5%) was the most common histological subtype. Majority patients had advanced stage at presentation (stage III/IV) (62.5%). Extranodal disease was present in 19.5% cases. GHSG early-favourable cases were 15.5%, early-unfavourable cases were 22.0%, while 62.5% were advanced cases. The most common chemotherapy regimen used was ABVD. Eighty-three (41.5%) patients received radiation therapy. Median follow-up was 34.2 months (range 4.1–67.8). The rates for complete response (CR), partial response (PR), stable disease (SD) and progressive disease (PD) were 84.5%, 8.5%, 5.0% and 2.0% respectively. PFS and OS rate at 6 years were 69.5% and 84.1% respectively. HL is one of the malignancies with high cure rate. The treatment outcome at our centre is comparable to western data and data from other tertiary centres from India.Keywords
This publication has 33 references indexed in Scilit:
- Improved population level survival in younger Hodgkin lymphoma patients in Germany in the early 21st centuryBritish Journal of Haematology, 2014
- Incidence Patterns and Outcomes for Hodgkin Lymphoma Patients in the United StatesAdvances in Hematology, 2010
- Early-Stage Hodgkin's LymphomaNew England Journal of Medicine, 2010
- Hodgkin’s lymphoma in Indian children: Prevalence and significance of Epstein–Barr virus detection in Hodgkin’s and Reed–Sternberg cellsEuropean Journal of Cancer, 2007
- Treatment of Hodgkin's Disease: A Twenty-Year Follow-up of Patients at a Center in KoreaYonsei Medical Journal, 2006
- Hodgkin's disease in Indian children: Outcome with chemotherapy alonePediatric Blood & Cancer, 2005
- Part II: Hodgkin's lymphoma—diagnosis and treatmentThe Lancet Oncology, 2004
- Consolidation Radiation After Complete Remission in Hodgkin's Disease Following Six Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Chemotherapy: Is There a Need?Journal of Clinical Oncology, 2004
- Hodgkin’s lymphoma: immunohistochemical features and its association with EBV LMP-1. Experience from a South Indian hospitalPathology, 2003
- A Prognostic Score for Advanced Hodgkin's DiseaseNew England Journal of Medicine, 1998